Aptus Pharma SME IPO Subscription Status
Aptus Pharma SME IPO closed on 25 September 2025 with an overall subscription of 22.27x based on shares applied. QIB demand came in at 1.24x, NII at 29.11x, and retail at 31.54x.
Allotment will be finalised on 26 September 2025. The stock is scheduled to list on NSE and BSE on 30 September 2025.
Issue Price
Rs 70.00
GMP Today
Rs 4.00 (+5.71%)
Overall Subscription
22.27x
Issue Size
₹12.36 Cr
Allotment Date
26 Sept 2025
Listing Date
30 Sept 2025
Aptus Pharma SME IPO Subscription by Amount
Category-wise subscription based on amount applied at issue price Rs 70.00
| Category | Amount Offered | Amount Applied | Subscription |
|---|---|---|---|
| QIB | Rs 2.46 Cr | Rs 3.05 Cr | 1.24x |
| FII | - | Rs 3.01 Cr | - |
| DFI | - | - | - |
| Mutual Funds | - | - | - |
| Other | - | Rs 4.20 L | - |
| NII | Rs 1.86 Cr | Rs 54.19 Cr | 29.11x |
| bNII (above Rs 10L) | Rs 1.24 Cr | Rs 38.84 Cr | 31.29x |
| Corporate | - | Rs 2.48 Cr | - |
| Individual | - | Rs 36.25 Cr | - |
| Other | - | Rs 11.20 L | - |
| sNII (Rs 2L to Rs 10L) | Rs 62.07 L | Rs 15.36 Cr | 24.74x |
| Corporate | - | Rs 25.20 L | - |
| Individual | - | Rs 14.77 Cr | - |
| Other | - | Rs 33.60 L | - |
| IND | Rs 4.34 Cr | Rs 136.86 Cr | 31.54x |
| Fixed price | - | Rs 136.86 Cr | - |
| Total | Rs 8.67 Cr | Rs 194.11 Cr | 22.40x |
Aptus Pharma SME IPO Subscription by Applications
Category-wise subscription based on applications received
| Category | Applications Offered | Applications Received | Subscription |
|---|---|---|---|
| QIB | 176 | 3 | 0.02x |
| FII | - | 2 | - |
| DFI | - | - | - |
| Mutual Funds | - | - | - |
| Other | - | 1 | - |
| NII | 44 | 664 | 15.09x |
| bNII (above Rs 10L) | 29 | 326 | 11.24x |
| Corporate | - | 12 | - |
| Individual | - | 313 | - |
| Other | - | 1 | - |
| sNII (Rs 2L to Rs 10L) | 15 | 338 | 22.53x |
| Corporate | - | 6 | - |
| Individual | - | 324 | - |
| Other | - | 8 | - |
| IND | 155 | 4,888 | 31.54x |
| Fixed price | - | 4,888 | - |
| Total | 375 | 5,555 | 14.81x |
What Do These Subscription Numbers Mean?
A subscription of 22.27x by shares means the IPO received bids for 22 times the shares reserved. Allotment odds depend on application count in each category, not share volume.
Here is what each category number tells you:
QIB at 1.24x by shares: This is the strongest signal on the page. QIBs are institutional investors, mutual funds, foreign institutions, and banks. When they subscribe at 1.24x, it reflects serious institutional conviction.
NII at 15.09x by applications: NII includes high net worth individuals applying above Rs 2 lakh. Proportional allotment uses application subscription. bNII came in at 11.24x and sNII at 22.53x by applications. Share subscription was 29.11x. Allotment uses application count, not share volume.
At 31.54x subscription by applications, approximately 1 in 32 retail applicants can expect an allotment (~3% per application). Retail allotment is done by lottery when oversubscribed.
Aptus Pharma SME IPO Allotment Chances
Allotment odds below use application subscription (number of bids received), not share or amount subscribed.
Retail (IND)
- •Application subscription: 31.54x.
- •Allotment odds: about 1 in 32 (~3% chance per application).
- •Method: Lottery. If allotted, you receive at least one lot.
- •One application per PAN. Multiple eligible accounts in a household can improve overall family odds, not individual odds.
SHNI (Rs 2 lakh to Rs 10 lakh)
- •Application subscription: 22.53x.
- •Allotment odds: about 1 in 23 for a minimum-lot application (~4% of the applied lot on average).
- •Method: Proportional. Shares allotted are based on your bid size, not a lottery.
- •Share subscription was 24.74x. Allotment uses application count, not share volume.
BHNI (above Rs 10 lakh)
- •Application subscription: 11.24x.
- •Allotment odds: about 1 in 11 for a minimum-lot application (~9% of the applied lot on average).
- •Method: Proportional. Shares allotted are based on your bid size, not a lottery.
- •Share subscription was 31.29x. Allotment uses application count, not share volume.
Check the Aptus Pharma SME IPO Allotment Status page from 26 September 2025 for your allotment result.
Aptus Pharma SME IPO GMP After Subscription
GMP for Aptus Pharma SME stands at Rs 4.00 today, giving an estimated listing price of Rs 74.00 per share.
A subscription of 22.27x combined with a GMP of 5.71% is a strong combination heading into listing. QIB demand above 50x in particular tends to support listing sentiment, as institutional investors are seen as informed buyers.
Track live GMP on the Aptus Pharma SME IPO GMP Today page or the IPOwiz Live IPO GMP Tracker.
Aptus Pharma SME IPO Day-wise Subscription
| Day | QIB | NII | Retail | Overall |
|---|---|---|---|---|
| Day 1 - 23 Sept 2025 | 0.00x | 4.78x | 1.77x | 1.92x |
| Day 2 - 24 Sept 2025 | 0.81x | 6.16x | 5.46x | 4.29x |
| Day 3 - 25 Sept 2025 | 1.24x | 28.75x | 31.43x | 22.27x |
Aptus Pharma SME IPO Key Dates
| Event | Date |
|---|---|
| IPO Open Date | 23 September 2025 |
| IPO Close Date | 25 September 2025 |
| Allotment Date | 26 September 2025 |
| Refund Initiation | 27 September 2025 |
| Share Credit to Demat | 27 September 2025 |
| Listing Date | 30 September 2025 |
| Minimum Investment | Rs 2,80,000.00 |
| Lot Size | 2000 shares |
About Aptus Pharma SME
No company information available
Understanding Subscription Categories
QIB - Qualified Institutional Buyers
Includes foreign institutional investors, domestic financial institutions, mutual funds, and other qualified institutions. QIB demand is considered the most reliable indicator of institutional confidence in an IPO.
NII - Non-Institutional Investors
High net worth individuals applying above Rs 2 lakh. Divided into bNII (above Rs 10 lakh) and sNII (Rs 2 lakh to Rs 10 lakh). NII allotment is proportional.
IND - Individual Investors
Investors applying up to Rs 2 lakh per PAN. Allotment is by lottery when oversubscribed. Minimum one lot per successful applicant.
Aptus Pharma SME IPO Subscription FAQs
What is Aptus Pharma SME IPO subscription status today?
Aptus Pharma SME IPO subscription closed on 25 September 2025 with overall subscription of 22.27x (by shares) as of 27 June 2026, 2:47 AM IST. QIB 1.24x, NII 15.09x, IND 31.54x.
What is the overall subscription of Aptus Pharma SME IPO?
Aptus Pharma SME IPO is subscribed 22.27x overall by shares at close on 25 September 2025. QIB 1.24x, NII 15.09x, and IND 31.54x.
What is Aptus Pharma SME IPO QIB subscription?
Aptus Pharma SME IPO QIB (Qualified Institutional Buyers) subscription is 1.24x by shares. QIB includes mutual funds, FIIs, banks, and other institutions.
What is Aptus Pharma SME IPO IND subscription?
Aptus Pharma SME IPO IND subscription is 31.54x by applications. Minimum retail bid is up to Rs 2 lakh per PAN.
What is Aptus Pharma SME IPO NII subscription?
Aptus Pharma SME IPO NII (Non-Institutional Investors) subscription is 15.09x by applications. NII covers bids above Rs 2 lakh.
What are allotment chances in Aptus Pharma SME IPO for retail?
At 31.54x subscription by applications, approximately 1 in 32 retail applicants can expect an allotment (~3% per application). Allotment is done by lottery.
When is Aptus Pharma SME IPO allotment date?
Aptus Pharma SME IPO allotment date is 26 September 2025. Check Aptus Pharma SME IPO Allotment Status on IPOwiz from that day using your PAN.
When does Aptus Pharma SME IPO subscription close?
Aptus Pharma SME IPO subscription closed on 25 September 2025. No new applications are accepted after the close.
What is Aptus Pharma SME IPO GMP today?
Aptus Pharma SME IPO GMP is ₹4 today (+5.71% over issue price ₹70). See live GMP on the Aptus Pharma SME IPO GMP Today page.
What is Aptus Pharma SME IPO issue price and lot size?
Aptus Pharma SME IPO issue price is ₹70 per share. Lot size is 2000 shares. Minimum investment is ₹2,80,000 per lot (minimum 2 lots for SME). Issue size: ₹12.36 Cr.
When is Aptus Pharma SME IPO listing date?
Aptus Pharma SME IPO listing date is 30 September 2025 on NSE and BSE. Allotment is on 26 September 2025.
How does subscription affect Aptus Pharma SME IPO allotment?
Allotment odds in Aptus Pharma SME IPO depend on application subscription in each category, not share volume. Retail uses lottery when oversubscribed. NII proportional allotment at 15.09x by applications means roughly 1 in 15 for minimum-lot bids; bNII at 11.24x (~1 in 11). At 22.27x overall, competition is high.
For allotment results from 26 September 2025, visit the Aptus Pharma SME IPO Allotment Status page. For listing day updates on 30 September 2025, download the IPOwiz App.
Reviewed by Dinesh Agrawal
15+ years in Indian capital markets and IPO research. Subscription data verified before publish.